Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'

Leuk Lymphoma. 2020 Jan;61(1):248-249. doi: 10.1080/10428194.2019.1680843. Epub 2019 Oct 23.

Authors

María Isabel Prieto-Conde¹, Jorge Labrador², Gerardo Hermida², Sara Alonso³, Cristina Jiménez¹, María García-Alvarez¹, Alejandro Medina¹, Ana Balanzategui¹, Miguel Alcoceba¹, María Eugenia Sarasquete¹, Noemí Puig¹, Verónica González¹, Norma C Gutiérrez¹, Ramón García-Sanz¹, Marcos González-Díaz¹, María Del Carmen Chillón¹

Affiliations

¹ Servicio de Hematología, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
² Servicio de Hematología, Hospital Universitario de Burgos, Burgos, Spain.
³ Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, Spain.

PMID: 31642380
DOI: 10.1080/10428194.2019.1680843

No abstract available

Publication types

Letter
Comment

MeSH terms

Core Binding Factor Alpha 2 Subunit
Genomics
Germ Cells
Humans
Leukemia, Myeloid, Acute*
Myelodysplastic Syndromes*

Substances

Core Binding Factor Alpha 2 Subunit
RUNX1 protein, human